Progress continues in prediction of the response to treatment of RA

In 2022, advances in the prediction of the response to treatment in rheumatoid arthritis resulted from gene-expression profiling in synovial biopsy samples, assessment of the expression of interferon-response genes in the blood, and the application of machine learning to patients' clinical parameters and genetic variance.

Automated summary

In 2022, significant progress was made in predicting treatment response in rheumatoid arthritis. This was achieved through gene-expression profiling in synovial biopsy samples, assessment of interferon-response genes in the blood, and the application of machine learning to patients' clinical parameters and genetic variance.